Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

574 ARTÍCULOS , VIENDO DEL 496 AL 510

Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease

Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F.

Neuropharmacology. 2021 Jun 1;190:108352. doi: 10.1016/j.neuropharm.2020.108352. Epub 2020 Oct 6.

Physical exercise protocols in animal models of Alzheimer's disease: a systematic review

De Sousa RAL, Rodrigues CM, Mendes BF, Improta-Caria AC, Peixoto MFD, Cassilhas RC.

Metab Brain Dis. 2021 Jan;36(1):85-95. doi: 10.1007/s11011-020-00633-z. Epub 2020 Oct 23.

Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism

Xing S, Li Q, Xiong B, Chen Y, Feng F, Liu W, Sun H.

Med Res Rev. 2021 Mar;41(2):858-901. doi: 10.1002/med.21745. Epub 2020 Oct 25.

Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives

Sun BL, Chen Y, Fan DY, Zhu C, Zeng F, Wang YJ.

Sci China Life Sci. 2021 Jun;64(6):926-937. doi: 10.1007/s11427-020-1810-y. Epub 2020 Oct 23.

Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance

Wang L, Bharti, Kumar R, Pavlov PF, Winblad B.

Eur J Med Chem. 2021 Jan 1;209:112915. doi: 10.1016/j.ejmech.2020.112915. Epub 2020 Oct 15.

Novel target for treating Alzheimer's Diseases: Crosstalk between the Nrf2 pathway and autophagy

Zhang W, Feng C, Jiang H.

Ageing Res Rev. 2021 Jan;65:101207. doi: 10.1016/j.arr.2020.101207. Epub 2020 Nov 1.

Antimicrobial therapy and the potential mechanisms in Alzheimer's disease

Song X, Chen J, Hou Z, Xie N.

Neurosci Lett. 2021 Jan 10;741:135464. doi: 10.1016/j.neulet.2020.135464. Epub 2020 Nov 6.

Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments

Bautista-Aguilera ÓM, Ismaili L, Iriepa I, Diez-Iriepa D, Chabchoub F, Marco-Contelles J, Pérez M.

Chem Rec. 2021 Jan;21(1):162-174. doi: 10.1002/tcr.202000107. Epub 2020 Nov 10.

CD36 in Alzheimer's Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting

Dobri AM, Dudău M, Enciu AM, Hinescu ME.

Neuroscience. 2021 Jan 15;453:301-311. doi: 10.1016/j.neuroscience.2020.11.003. Epub 2020 Nov 17.

What are the difficulties of implementing innovative pharmacy practice models in the care of patients with dementia?

Wimo A.

Expert Rev Pharmacoecon Outcomes Res. 2021 Feb;21(1):1-4. doi: 10.1080/14737167.2021.1848551. Epub 2020 Nov 26.

New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease

Zhang F, Zhong RJ, Cheng C, Li S, Le WD.

Acta Pharmacol Sin. 2021 Sep;42(9):1382-1389. doi: 10.1038/s41401-020-00565-5. Epub 2020 Dec 2.

Role of reactive oxygen species in the progression of Alzheimer's disease

Bhatt S, Puli L, Patil CR.

Drug Discov Today. 2021 Mar;26(3):794-803. doi: 10.1016/j.drudis.2020.12.004. Epub 2020 Dec 8.

Recent Advances in Virtual Screening for Cholinesterase Inhibitors

Miles JA, Ross BP.

ACS Chem Neurosci. 2021 Jan 6;12(1):30-41. doi: 10.1021/acschemneuro.0c00627. Epub 2020 Dec 22.

Deep Brain Stimulation for Alzheimer's Disease: Tackling Circuit Dysfunction

Lam J, Lee J, Liu CY, Lozano AM, Lee DJ.

Neuromodulation. 2021 Feb;24(2):171-186. doi: 10.1111/ner.13305. Epub 2020 Dec 30.

Alpiniae oxyphyllae Fructus and Alzheimer's disease: An update and current perspective on this traditional Chinese medicine

Li J, Du Q, Li N, Du S, Sun Z.

Biomed Pharmacother. 2021 Mar;135:111167. doi: 10.1016/j.biopha.2020.111167. Epub 2020 Dec 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias